No Picture
Los Angeles Biotech News

AltaSea at Forefront of ?Ocean Economy? Jobs Category Designated by LA County Economic Development Corporation ? First New Category in 10+ Years

LOS ANGELES–(BUSINESS WIRE)–AltaSea at the Port of Los Angeles and the Los Angeles Economic Development Corporation (LAEDC) co-authored a report that includes the first new category of jobs?the ?Ocean Economy??in Los Angeles in more than a decade. Th… […]

No Picture
Los Angeles Biotech News

Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund

IRVINE, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) (the ?Company? or ?Biomerica?) announced today that the Company completed a private placement of $2 million of convertible preferred stock with Palm Global Small Cap Mast… […]

No Picture
Los Angeles Biotech News

Happy Money? and Teachers Federal Credit Union Start Strategic Partnership

COSTA MESA, Calif.–(BUSINESS WIRE)–Happy Money, a fintech company building financial tools and services for human happiness, today announced the launch of its partnership with Teachers Federal Credit Union (TFCU), Hauppauge, NY. This announcement con… […]

No Picture
Los Angeles Biotech News

Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4

SANTA MONICA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (?Opiant?) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced that it will report its fin… […]

No Picture
Los Angeles Biotech News

The fourth CGRP migraine drug is here. Time for Lundbeck to prove it’s worth $2B

They may be late, but Lundbeck is now officially in the game for preventing migraine with CGRP drugs.
The FDA has OK?d eptinezumab, the prize in Lundbeck?s $2 billion acquisition of Alder. Like rival offerings from Amgen/Novartis, Eli Lilly and Teva, t… […]